Halpern Financial »

Aclaris Therapeutics shares owned by Halpern Financial

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Halpern Financial from 13F filings

Historical chart of Halpern Financial investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Halpern Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Halpern Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.8k 1.5k 1.17
2024-06-30 $1.7k 1.5k 1.10
2024-03-31 $1.9k 1.5k 1.25
2023-12-31 $1.7k 1.5k 1.12

More positions owned by Halpern Financial

Ishares S&p 500 Value Etf Etf (IVE)
Ishares S&p 500 Index Etf (IVV)
Ishares Msci Usa Min Vol Factor Etf Etf (USMV)
Spdr Portfolio Developed World Ex-us Etf Etf (SPDW)
Ishares S&p 500 Growth Etf Etf (IVW)
Schwab Us Dividend Equity Etf Etf (SCHD)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Jpmorgan Equity Premium Income Etf Etf (JEPI)
Vanguard Small Cap Etf Etf (VB)
Ishares S&p Smallcap 600 Etf Etf (IJR)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard S&p 500 Etf Etf (VOO)
Jpmorgan Inflation Managed Bond Etf Etf (JCPI)
Fidelity Msci Information Technology Index Etf Etf (FTEC)
Ishares Russell 1000 Growth Etf Etf (IWF)

View all positions for Halpern Financial

Top funds holding Aclaris Therapeutics

BML Capital Management
Vanguard Group
D. E. Shaw & Co
Millennium Management
Rock Springs Capital Management
Stonepine Capital Management
Acadian Asset Management
BlackRock
Renaissance Technologies
Two Sigma Advisers
Aldebaran Capital
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Two Sigma Investments
Geode Capital Management

View all funds holding Aclaris Therapeutics